These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34002172)

  • 21. An ecological study of socioeconomic predictors in detection of COVID-19 cases across neighborhoods in New York City.
    Whittle RS; Diaz-Artiles A
    BMC Med; 2020 Sep; 18(1):271. PubMed ID: 32883276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: Results from an observational cohort study.
    Martin CA; Jenkins DR; Minhas JS; Gray LJ; Tang J; Williams C; Sze S; Pan D; Jones W; Verma R; Knapp S; Major R; Davies M; Brunskill N; Wiselka M; Brightling C; Khunti K; Haldar P; Pareek M;
    EClinicalMedicine; 2020 Aug; 25():100466. PubMed ID: 32840492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK.
    Perry M; Akbari A; Cottrell S; Gravenor MB; Roberts R; Lyons RA; Bedston S; Torabi F; Griffiths L
    Vaccine; 2021 Oct; 39(42):6256-6261. PubMed ID: 34544601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who is accessing community lateral flow device testing and why? Characteristics and motivations of individuals participating in COVID-19 community testing in two English local authority areas.
    Dalili MN; Long J; Wadley E; Sloan J; Cross A; Thomas KH; Morgan G
    BMC Public Health; 2022 Mar; 22(1):588. PubMed ID: 35337297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daily testing of contacts of SARS-CoV-2 infected cases as an alternative to quarantine for key workers in Liverpool: A prospective cohort study.
    Marsden L; Hughes DM; Corcoran R; Cheyne CP; Ashton M; Buchan I; Coffey E; García-Fiñana M
    EClinicalMedicine; 2022 Aug; 50():101519. PubMed ID: 35795716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people.
    Shah SA; Brophy S; Kennedy J; Fisher L; Walker A; Mackenna B; Curtis H; Inglesby P; Davy S; Bacon S; Goldacre B; Agrawal U; Moore E; Simpson CR; Macleod J; Cooksey R; Sheikh A; Katikireddi SV
    EClinicalMedicine; 2022 Jul; 49():101462. PubMed ID: 35611160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social deprivation and SARS-CoV-2 testing: a population-based analysis in a highly contrasted southern France region.
    Landier J; Bassez L; Bendiane MK; Chaud P; Franke F; Nauleau S; Danjou F; Malfait P; Rebaudet S; Gaudart J
    Front Public Health; 2023; 11():1162711. PubMed ID: 37250096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of national-scale targeted point-of-care symptomatic lateral flow testing on trends in COVID-19 infections, hospitalisations and deaths during the second epidemic wave in Austria (REAP3).
    Reitzinger S; Czypionka T; Lammel O; Panovska-Griffiths J; Leber W
    BMC Public Health; 2023 Mar; 23(1):506. PubMed ID: 36927503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis.
    Riou J; Panczak R; Althaus CL; Junker C; Perisa D; Schneider K; Criscuolo NG; Low N; Egger M
    Lancet Public Health; 2021 Sep; 6(9):e683-e691. PubMed ID: 34252364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Test performance of lateral flow rapid antigen tests for COVID-19 in Welsh adult care home staff using routine surveillance data.
    Hogg C; Boots S; Howorth D; Williams C; Heginbothom M; Salmon J; Howe R
    PLoS One; 2023; 18(8):e0290406. PubMed ID: 37611000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of COVID-19 in the UK using self-reported symptoms: a large-scale, prospective, epidemiological surveillance study.
    Canas LS; Sudre CH; Capdevila Pujol J; Polidori L; Murray B; Molteni E; Graham MS; Klaser K; Antonelli M; Berry S; Davies R; Nguyen LH; Drew DA; Wolf J; Chan AT; Spector T; Steves CJ; Ourselin S; Modat M
    Lancet Digit Health; 2021 Sep; 3(9):e587-e598. PubMed ID: 34334333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
    Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
    Elife; 2023 Jan; 12():. PubMed ID: 36692910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    Martin CA; Pan D; Melbourne C; Teece L; Aujayeb A; Baggaley RF; Bryant L; Carr S; Gregary B; Gupta A; Guyatt AL; John C; McManus IC; Nazareth J; Nellums LB; Reza R; Simpson S; Tobin MD; Woolf K; Zingwe S; Khunti K; Abrams KR; Gray LJ; Pareek M;
    PLoS Med; 2022 May; 19(5):e1004015. PubMed ID: 35617423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    Martin CA; Marshall C; Patel P; Goss C; Jenkins DR; Ellwood C; Barton L; Price A; Brunskill NJ; Khunti K; Pareek M
    PLoS Med; 2021 Nov; 18(11):e1003823. PubMed ID: 34739480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 risk mitigation in reopening mass cultural events: population-based observational study for the UK Events Research Programme in Liverpool City Region.
    Burnside G; Cheyne CP; Leeming G; Humann M; Darby A; Green MA; Crozier A; Maskell S; O'Halloran K; Musi E; Carmi E; Khan N; Fisher D; Corcoran R; Dunning J; Edmunds WJ; Tharmaratnam K; Hughes DM; Malki-Epshtein L; Cook M; Roberts BM; Gallagher E; Howell K; Chand M; Kemp R; Boulter M; Fowler T; Semple MG; Coffey E; Ashton M; ; García-Fiñana M; Buchan IE
    J R Soc Med; 2024 Jan; 117(1):11-23. PubMed ID: 37351911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study.
    Bright D; Song J; Hillier S; Huws DW; Greene G; Hodgson K; Akbari A; Griffiths R; Davies AR; Gjini A
    Lancet; 2022 Nov; 400 Suppl 1():S25. PubMed ID: 36929968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Who is engaging with lateral flow testing for COVID-19 in the UK? The COVID-19 Rapid Survey of Adherence to Interventions and Responses (CORSAIR) study.
    Smith LE; Potts HW; Amlôt R; Fear NT; Michie S; Rubin GJ
    BMJ Open; 2022 Feb; 12(2):e058060. PubMed ID: 35144956
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.